Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

Fig. 1

Analysis of the CAF levels in blood and bone marrow plasma samples of MM patients. No differences are evident in their concentration between peripheral blood and bone marrow samples. Significantly higher levels of CAFs are detected in blood and bone marrow samples of MM patients as compared with control subjects (p < 0.0001 for all cytokines)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us